Rapid Assessment of Molecular Similarity between a Candidate Biosimilar and an Innovator Monoclonal Antibody Using Complementary LC–MS Methods - Intact protein LC–MS detected a mass varian


Rapid Assessment of Molecular Similarity between a Candidate Biosimilar and an Innovator Monoclonal Antibody Using Complementary LC–MS Methods
Intact protein LC–MS detected a mass variance of 62 Da and peptide mapping located a difference of two amino acids.

BioPharm International Supplements


1. Hughes B. Gearing up for follow-on biologics. Nat Rev Drug Discov. 2009;8:181.

2. The Patient Protection and Affordable Care Act, Pub.L. 111–148, 124 Stat. 119 (Mar 23, 2010).

3. Beck A, Bussat MC, Zorn N, Robillard V, Klinguer-Hamour C, Chenu S, et al. Characterization by liquid chromatography combined with mass spectrometry of monoclonal anti-IGF-1 receptor antibodies produced in CHO and NS0 cells. J Chromatogr B Analyt Technol Biomed Life Sci. 2005;819:203-18.

4. Reichert JM, Beck A, Iyer, H. European Medicines Agency workshop on biosimilar monoclonal antibodies, 2 July 2009, London, UK. MAbs. 2009;1:394–416.

5. European Commission. Guideline on Similar Biological Medicinal Products containing Biotechnology-derived proteins as active substance: Quality Issues. Brussels, Belgium; 2006 June. Available from: http://www.ema.europa.eu/pdfs/human/biosimilar/4934805en.pd.

6. Silva JC, Denny R, Dorschel C, Gorenstein MV, Li GZ, Richardson K, et al. Simultaneous qualitative and quantitative analysis of the Escherichia coli proteome: a sweet tale. Mol Cell Proteomics. 2006;5:589–607.

7. Silva JC, Gorenstein MV, Li GZ, Vissers JP, Geromanos SJ. Absolute quantification of proteins by LCMSE: A virtue of parallel MS acquisition. Mol Cell Proteomics. 2006;5:144–56.

8. Xie H, Gilar M, Gebler JC. Characterization of protein impurities and site-specific modifications using peptide mapping with liquid chromatography and data independent acquisition mass spectrometry. Anal Chem. 2009;81:5699–708.

9. Xie H, Chakraborty A, Ahn J, Yu YQ, Dakshinamoorthy DP, Gilar M, et al. Rapid comparison of a candidate biosimilar to an innovator monoclonal antibody with advanced liquid chromatography and mass spectrometry technologies. MAbs. 2010;2:4.

10. Ahn J, Bones J, Yu YQ, Rudd PM, Gilar M. Separation of 2-aminobenzamide labeled glycans using hydrophilic interaction chromatography columns packed with 1.7 microm sorbent. J. Chromatogr B Analyt Technol Biomed Life Sci. 2009;878:403–8.

11. Chakraborty AB, Berger SJ, Gebler JC; Waters Corporation. Biopharmaceutical Applications Notebook: A Focus on Protein Therapeutics. Waters application note 2007;720002439en.

12. Harris RJ, Kabakoff B, Macchi FD, Shen FJ, Kwong M, Andya JD, Shire SJ, Bjork N, Totpal K, Chen AB. Identification of multiple sources of charge heterogeneity in a recombinant antibody. J Chromatogr B Biomed Sci Appl. 2001;752:233–45.

13. DrugBank.ca [web site]. Alberta, Canada: David Wishart, Departments of Computing Science & Biological Sciences, University of Alberta. [cited 2010 July 9]. Available from http://www.drugbank.ca/drugs/DB00072.

14. Jefferis R, Lefranc MP. Human immunoglobulin allotypes: possible implications for immunogenicity. MAbs. 2009;1:332–8.

blog comments powered by Disqus



Bristol-Myers Squibb and Five Prime Therapeutics Collaborate on Development of Immunomodulator
November 26, 2014
Merck Enters into Licensing Agreement with NewLink for Investigational Ebola Vaccine
November 25, 2014
FDA Extends Review of Novartis' Investigational Compound for Multiple Myeloma
November 25, 2014
AstraZeneca Expands Biologics Manufacturing in Maryland
November 25, 2014
GSK Leads Big Pharma in Making Its Medicines Accessible
November 24, 2014
Author Guidelines
Source: BioPharm International Supplements,
Click here